HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ultralente insulin treatment of transient neonatal diabetes mellitus.

Abstract
In an infant with transient neonatal diabetes mellitus, control of the blood glucose concentration was attained with ultralente insulin treatment, without any episodes of hypoglycemia. We recommend subcutaneous injection of ultralente insulin, rather than lente or isophane (NPH) insulin, to avoid hypoglycemia during the treatment of transient neonatal diabetes mellitus.
AuthorsR Mitamura, H Kimura, Y Murakami, K Nagaya, Y Makita, A Okuno
JournalThe Journal of pediatrics (J Pediatr) Vol. 128 Issue 2 Pg. 268-70 (Feb 1996) ISSN: 0022-3476 [Print] United States
PMID8636827 (Publication Type: Journal Article)
Chemical References
  • Insulin, Long-Acting
Topics
  • Diabetes Mellitus (drug therapy)
  • Female
  • Humans
  • Infant, Newborn
  • Injections, Subcutaneous
  • Insulin, Long-Acting (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: